Dexcom Inc (DXCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Sales | 1,036,000 | 1,113,500 | 994,200 | 1,004,300 | 921,000 |
| Cost of Goods | 447,000 | 457,700 | 400,400 | 377,600 | 359,100 |
| Gross Profit | 589,000 | 655,800 | 593,800 | 626,700 | 561,900 |
| Operating Expenses | 455,300 | 467,600 | 442,200 | 469,300 | 460,900 |
| Operating Income | 133,700 | 188,900 | 152,000 | 158,000 | 101,100 |
| Other Income | 20,600 | 22,400 | 25,400 | 29,800 | 31,400 |
| Pre-tax Income | 154,300 | 211,300 | 177,400 | 187,800 | 132,500 |
| Income Tax | 48,900 | 59,600 | 42,800 | 44,300 | -13,900 |
| Net Income Continuous | 105,400 | 151,700 | 134,600 | 143,500 | 146,400 |
| Net Income | $105,400 | $151,700 | $134,600 | $143,500 | $146,400 |
| EPS Basic Total Ops | 0.27 | 0.38 | 0.34 | 0.36 | 0.38 |
| EPS Basic Continuous Ops | 0.27 | 0.39 | 0.34 | 0.36 | 0.38 |
| EPS Diluted Total Ops | 0.27 | 0.37 | 0.34 | 0.35 | 0.36 |
| EPS Diluted Continuous Ops | 0.26 | 0.37 | 0.33 | 0.34 | 0.35 |
| EPS Diluted Before Non-Recurring Items | 0.32 | 0.45 | 0.45 | N/A | N/A |
| EBITDA(a) | $193,700 | $246,700 | $207,300 | $210,100 | $153,600 |